Aclarubicin (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Nadolol Manufacturers of Nadolol Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Nadolol's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 25 to 100 mg/sq.meter62 (62.5)As recommended.IVMaintenance, Every 3-4 Weeks175 to 300 mg/sq.meter240 (237.5)24 hourlyIVInitially for 3-7 Days Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Nadolol is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Nadolol is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Nadolol Back to top Manufacturers of Aclarubicin (HCl) in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Aclarubicin (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Nadolol Manufacturers of Nadolol Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Nadolol's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 25 to 100 mg/sq.meter62 (62.5)As recommended.IVMaintenance, Every 3-4 Weeks175 to 300 mg/sq.meter240 (237.5)24 hourlyIVInitially for 3-7 Days Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Nadolol is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Nadolol is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Nadolol Back to top Manufacturers of Aclarubicin (HCl) in Pakistan Back to top Previous Drug Generic - Next Drug Generic